Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine and Lopinavir/ Ritonavir for Hospitalization and Mortality Reduction in Patients With COVID-19 and Mild Disease Symptoms: "The Hope Coalition"

NCT04403100 is registered in ClinicalTrials.gov with Cardresearch as lead sponsor.

NCT NCT04403100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04403100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine and Lopinavir/ Ritonavir for Hospitalization and Mortality Reduction in Patients With COVID-19 and Mild Disease Symptoms: "The Hope Coalition"
Lead sponsor
Cardresearch
Phase
Phase 3
Overall status
Unknown status
Start date
June 3, 2020
Completion date
February 1, 2021
Enrollment
1,968 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, coronavirus infection, covid-19, sars-cov infection, virus disease